CT for Personalized Mechanical Ventilation

Sponsor
Columbia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05977153
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
12
1
2
20.8
0.6

Study Details

Study Description

Brief Summary

The goal of this study is to compare two different ways of helping patients with a condition called sepsis who need help breathing using a machine called a ventilator. The investigators want to study which way of setting the ventilator is better for the lungs.

Here are the main questions the investigators want to answer:
  1. How does the amount of air in the lungs and the way it moves differ between the two ways?

  2. How does the way air spreads out in different parts of the lungs differ between the two ways? In this study, the investigators will take special pictures of the lungs using a machine called a CT scan. The pictures will show us how much the lungs stretch and how much air is in different parts of the lungs. The investigators will compare two different ways of using the ventilator: one personalized for each patient based on their breathing, and another way that is commonly used.

By comparing these two ways, the investigators hope to learn which one is better for helping patients with sepsis who need the ventilator. This information can help doctors make better decisions about how to care for these patients and improve their breathing.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PEEP (positive end-expiratory pressure) - maximum
  • Procedure: PEEP (positive end-expiratory pressure) - standard
N/A

Detailed Description

Mechanical ventilation is a key life support method applied to millions of surgical and critically ill patients. Ventilator-induced lung injury (VILI) is a major factor for morbidity and mortality in patients with the acute respiratory distress syndrome (ARDS), the most severe form of respiratory dysfunction. Furthermore, mechanical ventilation settings also contribute to the risk for postoperative pulmonary complications (PPCs) in surgical patients and lung injury in critically ill patients with normal lungs at onset of ventilation. In summary, mitigation of VILI is critical to reduce perioperative and critical care morbidity and mortality, with major impact on outcomes and health care costs.

In this project, we propose to apply novel CT methods to assess spatial distributions of strain and aeration and establish measures of global lung mechanics best indicative of the PEEP leading to least injurious distributions and, thus, least VILI.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
CT-Guided Personalized Mechanical Ventilation to Minimize Ventilator-Induced Lung Injury Study
Actual Study Start Date :
May 10, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group 1: ARDSNet

Participants will receive standard ARDSNet low-stretch PEEP (positive end-expiratory pressure) protocol.

Procedure: PEEP (positive end-expiratory pressure) - standard
Breathing assistance from the breathing assist machine using the pressure settings typical for your disease. Standard ARDSNet low-stretch PEEP (positive end-expiratory pressure) protocol: PEEP will be set following a routinely used PEEP table according to patients' blood oxygenation status.

Experimental: Group 2: Individualized PEEP (positive end expiratory pressure) Strategy

Participants will receive individualized PEEP (positive end-expiratory pressure).

Procedure: PEEP (positive end-expiratory pressure) - maximum
Breathing assistance from the breathing assist machine using a method in which doctors try to find the pressures that expands the lungs the best. This is based on measurements of one's respiratory pressures and volumes. This is done by adjusting the pressure settings. This allows one's lungs to expand with the least amount of change in pressure during breathing. PEEP (positive end-expiratory pressure) will be set at the maximum static respiratory system compliance (Crs) during a descending PEEP titration curve.

Outcome Measures

Primary Outcome Measures

  1. Squared coefficient of variation of the tidal volumetric strain [48 hours]

    Squared coefficient of variation (=variance normalized by the squared mean) of the tidal volumetric strain will be obtained and calculated from CT images.

Secondary Outcome Measures

  1. Squared coefficient of variation of aeration [48 hours]

    Squared coefficient of variation (=variance normalized by the squared mean) of aeration obtained and calculated from CT images.

  2. Average gas fraction [48 hours]

    Average gas fraction will be obtained and calculated from CT images.

  3. Distribution of aeration categories [48 hours]

    Distribution of aeration categories (non-aerated, poorly aerated, normally aerated and hyperinflated regions) will be obtained and calculated from CT images.

  4. Average tidal strain [48 hours]

    Average of voxel level volumetric tidal strain will be obtained and calculated from CT images.

Other Outcome Measures

  1. Time during mechanical ventilation [Up to 5 days]

    Time during mechanical ventilation will be recorded in days.

  2. Detection of Inflammatory cytokines [48 hours]

    Inflammatory cytokine is a type of signaling molecule (a cytokine) that is secreted from immune cells like helper T cells (Th) and macrophages, and certain other cell types that promote inflammation; their presence will be measured by assays.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Following onset of mechanical ventilation and not longer than 5 days after intubation.

  • Sepsis as defined by the most recent criteria:

  • Life-threatening organ dysfunction caused by a dysregulated host response to infection operationalized by presumed or documented infection and a Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score >= 2 or a change by 2 from the baseline if baseline known to be different from 0;

Exclusion Criteria:
  • Age < 18 years;

  • Hemodynamic instability, defined as: systolic blood pressure (SBP) < 90 mmHg that is not adequately stabilized by vasopressors or inotropic agents. For these purposes, SBP will not be considered "adequately stabilized" if the dose of the vasopressor/inotrope has not been stable for at least one hour;

  • Hypoxemia, defined as: PaO2 < 70 mmHg on an inspired oxygen fraction (FiO2) greater than or equal to 0.9;

  • Hemodynamic and/or respiratory instability (as defined, in items 2 and 3) that develop when the patient is mobilized during routine nursing care such as repositioning/washing the patient or changing their bed linens;

  • Hemodynamic and/or respiratory instability (as defined, in items 2 and 3) that develop when a 20 second respiratory pause is required to implement the study protocol. This will be tested by inducing such a pause prior to transporting the patient;

  • Any acute or chronic condition which, in the opinion of the investigators, might confound the imaging measurements (such as, but not limited to, severe bronchospasm, pulmonary infection, and lung tumor);

  • Any acute or chronic condition which, in the opinion of the investigators or managing critical care team, could prevent safe transport to the CT suite.

  • "Air leaks" requiring tube thoracotomy (e.g., pneumothorax, bronchopleural fistula);

  • Body mass index > 40 kg/m2;

  • Pregnancy (since this is a study that would expose a fetus to radiation risk);

  • Patients who have taken part in other research studies involving radiation exposure, or those patients for whom this research radiation history is unavailable at the time of consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Columbia University New York New York United States 10025

Sponsors and Collaborators

  • Columbia University
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Marcos F VIdal Melo, MD/PhD, Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marcos Vidal Melo, Professor of Anesthesiology, Columbia University
ClinicalTrials.gov Identifier:
NCT05977153
Other Study ID Numbers:
  • AAAT8623
  • 5R01HL121228-09
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marcos Vidal Melo, Professor of Anesthesiology, Columbia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023